Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Boston Scientific Corporation

Market Cap 69.74B 60.1B 55.34B 51.96B 97.56B 6,594B 98.59B 654B 255B 3,229B 262B 256B 11,190B P/E Ratio 2026 *
17.2x
P/E Ratio 2027 * 16.4x
Enterprise Value 76.5B 65.93B 60.71B 57B 107B 7,233B 108B 717B 279B 3,542B 287B 281B 12,275B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.13x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+0.34%
1 week-4.17%
Current month-2.88%
1 month-10.93%
3 months-32.77%
6 months-49.52%
Current year-50.79%
1 week 45.99
Extreme 45.99
48.65
1 month 45.99
Extreme 45.99
58.51
Current year 45.99
Extreme 45.99
100.9
1 year 45.99
Extreme 45.99
109.5
3 years 45.99
Extreme 45.99
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
05-28Don

Chief Executive Officer

-386,755 0.0261%
05-20Buy

Director

3,580 0.0002%
05-20Buy

Director

2,250 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-4.17%-53.77%-13.62% 69.5B
-0.23%-4.34%+16.68%-12.04% 176B
+0.12%-2.24%-19.65%+26.63% 148B
+0.14%-3.75%-9.83%-25.00% 128B
+2.67%+1.19%+18.39%-3.65% 49.68B
+0.97%+0.60%-23.33%-33.14% 45.26B
-1.72%-5.27%+7.83%+5.95% 36.88B
+0.78%-2.86%+3.66%+33.93% 35.13B
-2.36%-4.21%-13.22%-19.61% 29.46B
+0.62%-1.52%-22.94%-11.46% 27.84B
Average +0.13%-2.29%-9.62%-5.20% 74.55B
Weighted average by Cap. +0.14%-2.82%-7.66%-4.71%

Financials

2026 *2027 *
Net sales 21.6B 18.62B 17.14B 16.09B 30.22B 2,042B 30.54B 203B 78.91B 1,000B 81.06B 79.34B 3,466B 23.37B 20.14B 18.55B 17.42B 32.7B 2,210B 33.04B 219B 85.39B 1,082B 87.72B 85.86B 3,750B
Net income 3.91B 3.37B 3.1B 2.91B 5.47B 370B 5.53B 36.65B 14.28B 181B 14.67B 14.36B 627B 4.14B 3.57B 3.28B 3.08B 5.79B 391B 5.85B 38.8B 15.11B 192B 15.53B 15.2B 664B
Net Debt 6.76B 5.83B 5.37B 5.04B 9.46B 640B 9.56B 63.43B 24.71B 313B 25.39B 24.85B 1,085B 3.45B 2.97B 2.74B 2.57B 4.82B 326B 4.87B 32.33B 12.6B 160B 12.94B 12.67B 553B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
16/06/26 46.92 $ +0.34% 11,144,138
15/06/26 46.76 $ -0.32% 16,285,189
12/06/26 46.91 $ -0.55% 16,762,414
11/06/26 47.17 $ -2.42% 18,903,236
10/06/26 48.34 $ -1.27% 22,676,579
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
46.92USD
Average target price
77.10USD
Spread / Average Target
+64.32%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!